Europe clears Guidant's next-generation HF (heart failure) device:
This article was originally published in Clinica
Guidant has CE-marked for sale in Europe its next-generation cardiac resynchronisation device for treating heart failure (HF). The CONTAK RENEWAL, which also provides defibrillation therapy, contains new diagnostic capabilities that are designed to help physicians better manage their patients' condition. The product monitors heart rate variability and uses data from an accelerometer sensor to track trends in patients' activity levels.